The routine commissioning of rosuvastatin is accepted in Devon for primary and secondary prevention of cardiovascular disease for patients who are intolerant of other appropriate statins.
| Filename: | Rosuvastatin for primary and secondary prevention of cardiovascular disease |
| Filetype: | |
| Filesize: | 48.17 KB |
| Date uploaded: | 1st February 2021 |
| Date updated: | 8th December 2022 |
